Chronic outcome of percutaneous transcatheter patent foramen ovale closure with Left-disk-coated patent foramen ovale occluder
10.3760/cma.j.issn.0253-3758.2009.12.018
- VernacularTitle:经皮导管左盘外包膜卵圆孔封堵器治疗卵圆孔未闭
- Author:
Yi-Gao HUANG
1
;
Cao-Jin ZHANG
;
Xin-Sheng HUANG
;
Tao HUANG
;
Wen-Hui HUANG
Author Information
1. 广东省人民医院
- Keywords:
Heart septal defects;
atrial;
Heart catheterization;
Follow-up studies
- From:
Chinese Journal of Cardiology
2009;37(12):1132-1135
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the safety and efficacy of patent foramen ovale ( PFO ) closure with Left-disk-coated PFO occluder. Methods The device was implanted in patients with PFO under the guidance of fluoroscopy and transthoracal echocardiography using a 10-12 French delivery sheath via femoral vein approach. Aspirin (100 mg/d for 6 months) was administered post procedure. Patients were followed clinically and echocardiographically at 24 hours, 1 month, 3months, 6 months, and 12 months after device implantation and yearly thereafter. Results Permanent device implantation failed in one patient (4% ) and succeed in the remaining 24 patients (96% ) . There were no major in-hospital-adverse events or complications ( thromboembolism, occluder dislodgement, infection or myocardial infarction). Seven patients developed transient atrial premature beats or atrial tachycardia during implantation and stopped without medication post procedure. Follow-up [(25 ±12) months] results showed that all occluders were in position and there were no residual shunt, arrhythmia and cerebral vessel events post procedure. Conclusion Left-disk-coated PFO occluder is safe and effective for PFO closure.
